0001140361-15-043569.txt : 20151203 0001140361-15-043569.hdr.sgml : 20151203 20151203163509 ACCESSION NUMBER: 0001140361-15-043569 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20151201 FILED AS OF DATE: 20151203 DATE AS OF CHANGE: 20151203 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HEALTHEQUITY INC CENTRAL INDEX KEY: 0001428336 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE BUSINESS ADDRESS: STREET 1: 15 WEST SCENIC POINTE DRIVE STREET 2: SUITE 100 CITY: DRAPER STATE: UT ZIP: 84003 BUSINESS PHONE: 801-727-1000 MAIL ADDRESS: STREET 1: 15 WEST SCENIC POINTE DRIVE STREET 2: SUITE 100 CITY: DRAPER STATE: UT ZIP: 84003 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dreier Ashley CENTRAL INDEX KEY: 0001614957 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36568 FILM NUMBER: 151267766 MAIL ADDRESS: STREET 1: 15 W. SCENIC POINTE DR., STE. 100 CITY: DRAPER STATE: UT ZIP: 84020 4 1 doc1.xml FORM 4 X0306 4 2015-12-01 0 0001428336 HEALTHEQUITY INC HQY 0001614957 Dreier Ashley C/O HEALTHEQUITY, INC. 15 W. SCENIC POINTE DR., STE. 100 DRAPER UT 84020 0 1 0 0 Executive VP, CTO and CIO Common Stock 2015-12-01 4 M 0 3125 1.5 A 3125 D Common Stock 2015-12-01 4 S 0 1725 32.0083 D 1400 D Common Stock 2015-12-01 4 S 0 1400 32.71 D 0 D Stock Option (right to buy) 1.5 2015-12-01 4 M 0 3125 0 D 2023-05-09 Common Stock 3125 87500 D Stock Option (right to buy) 1.5 2023-05-09 Common Stock 100000 100000 D The option exercise and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 15, 2015. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.51 to $32.50, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes (2) and (3) to this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.55 to $32.82, inclusive. The option becomes exercisable in four equal installments on May 9, 2014, 2015, 2016 and 2017. As previously reported in the reporting person's Form 3, the option grant had a $2.50 exercise price upon issuance. The $2.50 exercise price was automatically adjusted to $1.50 on August 4, 2014 as a result of the occurrence of an event specified in the terms of the option grant at the time of its issuance. The option is immediately exercisable. /s/ Ashley Dreier 2015-12-03